NCT06640751 The Effect of Interventions for Health Behaviors in Hypertensive Patients
| NCT ID | NCT06640751 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing Medical University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2024-10-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.
Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with mild to moderate primary hypertension according to the diagnostic criteria of the "2018 Revised Edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension," whose blood pressure is not well controlled or who have poor treatment compliance; 2. Age greater than 18 years and less than 80 years; 3. Normal language communication ability and willingness to participate in the study; 4. Have lived in the community for at least 12 months. Exclusion Criteria: 1. Patients who lack basic behavioral abilities, have impaired memory function, or have limited language expression abilities; 2. Patients who are simultaneously participating in other intervention studies.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06640751 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06640751 currently recruiting?
Yes, NCT06640751 is actively recruiting participants. Contact the research team at heyuan@njmu.edu.cn for enrollment information.
Where is the NCT06640751 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT06640751 clinical trial?
NCT06640751 is sponsored by Nanjing Medical University. The trial plans to enroll 240 participants.